Suppr超能文献

评估三种旨在识别高危携带者夫妇的载体筛查工作流程的效果。

Evaluating the efficacy of three carrier screening workflows designed to identify at-risk carrier couples.

机构信息

Myriad Women's Health, South San Francisco, California, USA.

Myriad Genetics, Inc., Salt Lake City, Utah, USA.

出版信息

Prenat Diagn. 2021 Jun;41(7):896-904. doi: 10.1002/pd.5900. Epub 2021 Feb 8.

Abstract

OBJECTIVE

To evaluate the efficacy of three different carrier screening workflows designed to identify couples at risk for having offspring with autosomal recessive conditions.

METHODS

Partner testing compliance, unnecessary testing, turnaround time, and ability to identify at-risk couples (ARCs) were measured across all three screening strategies (sequential, tandem, or tandem reflex).

RESULTS

A total of 314,100 individuals who underwent carrier screening were analyzed. Sequential, tandem, and tandem reflex screening yielded compliance frequencies of 25.8%, 100%, and 95.9%, respectively. Among 14,595 couples tested in tandem, 42.2% of females were screen-negative, resulting in unnecessary testing of the male partner. In contrast, less than 1% of tandem reflex couples included unnecessary male testing. The median turnaround times were 29.2 days (sequential), 8 days (tandem), and 13.3 days (tandem reflex). The proportion of ARCs detected per total number of individual screens were 0.5% for sequential testing and 1.3% for both tandem and tandem reflex testing.

CONCLUSION

The tandem reflex strategy simplifies a potentially complex clinical scenario by providing a mechanism by which providers can maximize partner compliance and the detection of at-risk couples while minimizing workflow burden and unnecessary testing and is more efficacious than both sequential and tandem screening strategies.

摘要

目的

评估三种不同的携带者筛查工作流程的效果,这些工作流程旨在识别有生育常染色体隐性疾病子女风险的夫妇。

方法

在所有三种筛查策略(顺序、串联或串联反射)中,测量了伴侣检测的依从性、不必要的检测、周转时间和识别风险夫妇(ARCs)的能力。

结果

分析了 314100 名接受携带者筛查的个体。顺序、串联和串联反射筛查的依从性频率分别为 25.8%、100%和 95.9%。在 14595 对接受串联检测的夫妇中,42.2%的女性为筛查阴性,导致男性伴侣进行了不必要的检测。相比之下,不到 1%的串联反射夫妇包括不必要的男性检测。中位周转时间分别为 29.2 天(顺序)、8 天(串联)和 13.3 天(串联反射)。每进行一次个体筛查,检测到的 ARCs 比例分别为顺序检测的 0.5%,串联和串联反射检测的 1.3%。

结论

串联反射策略通过提供一种机制,简化了潜在复杂的临床情况,使提供者能够最大限度地提高伴侣的依从性和风险夫妇的检测率,同时最大限度地减少工作流程负担和不必要的检测,比顺序和串联筛查策略更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff06/8248057/47527ab734e6/PD-41-896-g001.jpg

相似文献

1
Evaluating the efficacy of three carrier screening workflows designed to identify at-risk carrier couples.
Prenat Diagn. 2021 Jun;41(7):896-904. doi: 10.1002/pd.5900. Epub 2021 Feb 8.
3
[Carrier screening for 223 monogenic diseases in Chinese population: a multi-center study in 33 104 individuals].
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jun 20;44(6):1015-1023. doi: 10.12122/j.issn.1673-4254.2024.06.01.
5
Expanded targeted preconception screening panel in Israel: findings and insights.
J Med Genet. 2024 Jul 19;61(8):783-787. doi: 10.1136/jmg-2023-109629.
6
Expanding families: a pilot study on preconception expanded carrier screening in Bahrain.
BMC Pregnancy Childbirth. 2024 Oct 18;24(1):684. doi: 10.1186/s12884-024-06878-1.
7
Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.
Obstet Gynecol. 2017 Aug;130(2):279-284. doi: 10.1097/AOG.0000000000002139.
10
Exome-based preconception carrier testing for consanguineous couples in China.
Prenat Diagn. 2021 Oct;41(11):1425-1429. doi: 10.1002/pd.6018. Epub 2021 Sep 9.

引用本文的文献

1
Clinical exome sequencing for carrier screening in assisted reproductive technology and sperm donation.
J Assist Reprod Genet. 2025 Apr;42(4):1247-1256. doi: 10.1007/s10815-025-03406-8. Epub 2025 Jan 30.
2
The completion of indicated paternal prenatal genetic and carrier testing at a public hospital in Los Angeles, California.
Genet Med Open. 2023 Sep 1;1(1):100831. doi: 10.1016/j.gimo.2023.100831. eCollection 2023.

本文引用的文献

2
Reproductive male partner testing when the female is identified to be a genetic disease carrier.
Prenat Diagn. 2021 Jan;41(1):21-27. doi: 10.1002/pd.5824. Epub 2020 Sep 24.
3
Evaluation and classification of severity for 176 genes on an expanded carrier screening panel.
Prenat Diagn. 2020 Sep;40(10):1246-1257. doi: 10.1002/pd.5762. Epub 2020 Jun 16.
4
Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach.
Genet Med. 2020 Aug;22(8):1320-1328. doi: 10.1038/s41436-020-0807-4. Epub 2020 May 5.
5
It takes two: uptake of carrier screening among male reproductive partners.
Prenat Diagn. 2020 Feb;40(3):311-316. doi: 10.1002/pd.5588. Epub 2019 Dec 2.
6
A data-driven evaluation of the size and content of expanded carrier screening panels.
Genet Med. 2019 Sep;21(9):1931-1939. doi: 10.1038/s41436-019-0466-5. Epub 2019 Feb 28.
7
Expanded carrier screening: a current survey of physician utilization and attitudes.
J Assist Reprod Genet. 2018 Sep;35(9):1631-1640. doi: 10.1007/s10815-018-1272-8. Epub 2018 Aug 1.
9
Systematic design and comparison of expanded carrier screening panels.
Genet Med. 2018 Jan;20(1):55-63. doi: 10.1038/gim.2017.69. Epub 2017 Jun 22.
10
Committee Opinion No. 691: Carrier Screening for Genetic Conditions.
Obstet Gynecol. 2017 Mar;129(3):e41-e55. doi: 10.1097/AOG.0000000000001952.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验